A recent clinical trial compares three cycles versus six cycles of CEV chemotherapy for high-risk retinoblastoma patients

How physical activity and better sleep patterns can reduce the mental health impact of visual impairment

The Power List celebrates the world’s most inspiring and influential ophthalmologists

Could emerging neuroprotective strategies represent a new era for retinal disease treatment?

Shanghai-based researchers investigate three metabolite biomarkers for diagnosing and monitoring age-related macular degeneration

The Ophthalmologist brings you the top news stories and studies of the week

What’s a fair price for eye surgery?

Why it is crucial to get ahead of seasonal symptoms in dry eye patients

Fred Guerard, PharmD, CEO of Opthea, outlines the clinical development of sozinibercept in combination with standard-of-care anti-VEGF-A therapies

Embracing continuous professional education and Advancing Ophthalmology